Good news for Boston as FDA approves leadless ICD, but firm still faces “battle” with Medtronic, St Jude
This article was originally published in Clinica
Executive Summary
Boston Scientific’s subcutaneous implantable cardioverter defibrillator (S-ICD), which it gained with its acquisition of Cameron Health, has become the first device of its kind to be approved by the US FDA.